Fresenius SE & Co. KGaA
General ticker "FSNUF" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $28.8B (TTM average)
Fresenius SE & Co. KGaA follows the US Stock Market performance with the rate: 26.5%.
Estimated limits based on current volatility of 0.7%: low 55.31$, high 56.04$
Factors to consider:
- Company pays dividends (annually): last record date 2026-05-26, amount 1.22$ (Y2.24%)
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [45.85$, 65.27$]
- 2026-12-31 to 2027-12-31 estimated range: [46.69$, 66.74$]
Short-term FSNUF quotes
Long-term FSNUF plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | €22,864.43MM |
| Operating Expenses | €20,687.25MM |
| Operating Income | €2,177.18MM |
| Non-Operating Income | €10.00MM |
| Interest Expense | €437.84MM |
| R&D Expense | €632.76MM |
| Income(Loss) | €2,187.18MM |
| Taxes | €581.78MM |
| Net Income(Loss)* | €1,263.53MM |
| Stockholders Equity | €19,096.85MM |
| Inventory | €2,610.02MM |
| Assets | €41,379.50MM |
| Operating Cash Flow | €2,693.99MM |
| Capital expenditure | €1,496.44MM |
| Investing Cash Flow | €-941.65MM |
| Financing Cash Flow | €-2,416.09MM |
| Earnings Per Share** | €2.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.